EPIDERMAL GROWTH FACTOR-UROGASTRONE AND TRANSFORMING GROWTH FACTOR-ALPHA - STRUCTURAL REQUIREMENTS FOR RECEPTOR-MEDIATED DESENSITIZATION

被引：0
|
作者：
YANG, SG [1 ]
ITOH, H [1 ]
MURAMATSU, T [1 ]
LEDERIS, K [1 ]
HOLLENBERG, MD [1 ]
机构：
[1] UNIV CALGARY,FAC MED,DEPT PHARMACOL & THERAPEUT,CALGARY T2N 4N1,ALBERTA,CANADA
来源：
FASEB JOURNAL | 1988年 / 2卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A625 / A625
页数：1
相关论文
共 50 条
  • [31] EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND TRANSFORMING GROWTH FACTOR-ALPHA IN HUMAN MYOGENIC SARCOMAS
    GALBEROGLIO, C
    CORDONCARDO, C
    SORVILLO, J
    CASPER, ES
    HOUGHTON, AN
    MENDELSOHN, J
    BRENNAN, MF
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1992, 11 (02) : 83 - 91
  • [32] TRANSFORMING GROWTH FACTOR-ALPHA BINDS TO THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN GASTRIC-MUCOSA
    BIELANSKI, WJ
    KEOGH, JP
    WANG, SL
    LIU, J
    KONTUREK, SJ
    SLOMIANY, A
    SLOMIANY, BL
    BIOCHEMISTRY INTERNATIONAL, 1991, 25 (03): : 419 - 427
  • [33] EXPRESSION OF TRANSFORMING GROWTH FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN FETAL KIDNEYS
    GOODYER, PR
    FATA, J
    MULLIGAN, L
    FISCHER, D
    FAGAN, R
    GUYDA, HJ
    GOODYER, CG
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1991, 77 (1-3) : 199 - 206
  • [34] EPIDERMAL GROWTH FACTOR-UROGASTRONE CAUSES VASODILATATION IN THE ANESTHETIZED DOG
    GAN, BS
    MACCANNELL, KL
    HOLLENBERG, MD
    JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (01): : 199 - 206
  • [35] IDENTIFICATION OF EPIDERMAL GROWTH-FACTOR, TRANSFORMING GROWTH FACTOR-ALPHA, AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN SURGICALLY INDUCED ENDOMETRIOSIS IN RATS
    SIMMS, JS
    CHEGINI, N
    WILLIAMS, RS
    ROSSI, AM
    DUNN, WA
    OBSTETRICS AND GYNECOLOGY, 1991, 78 (05): : 850 - 857
  • [36] GENES FOR EPIDERMAL GROWTH-FACTOR RECEPTOR, TRANSFORMING GROWTH FACTOR-ALPHA, AND EPIDERMAL GROWTH-FACTOR AND THEIR EXPRESSION IN HUMAN GLIOMAS INVIVO
    EKSTRAND, AJ
    JAMES, CD
    CAVENEE, WK
    SELIGER, B
    PETTERSSON, RF
    COLLINS, VP
    CANCER RESEARCH, 1991, 51 (08) : 2164 - 2172
  • [37] EPIDERMAL GROWTH FACTOR-UROGASTRONE - BIOLOGICAL-ACTIVITY AND RECEPTOR-BINDING OF DERIVATIVES
    HOLLENBERG, MD
    GREGORY, H
    MOLECULAR PHARMACOLOGY, 1980, 17 (03) : 314 - 320
  • [38] Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha
    Reddy, CC
    Wells, A
    Lauffenburger, DA
    JOURNAL OF CELLULAR PHYSIOLOGY, 1996, 166 (03) : 512 - 522
  • [39] DETECTION OF EPIDERMAL GROWTH FACTOR-UROGASTRONE AND ITS RECEPTOR DURING FETAL MOUSE DEVELOPMENT
    NEXO, E
    HOLLENBERG, MD
    FIGUEROA, A
    PRATT, RM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05): : 2782 - 2785
  • [40] IMMUNOREACTIVITY OF ANTIBODIES TO EPIDERMAL GROWTH-FACTOR, TRANSFORMING GROWTH FACTOR-ALPHA AND FACTOR-BETA, AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE PREMENOPAUSAL OVARY
    SCURRY, JP
    HAMAND, KA
    ASTLEY, SB
    LEAKE, RE
    WELLS, M
    PATHOLOGY, 1994, 26 (02) : 130 - 133
12345